Kopriva F, Szotkowská J, Plocová A, Závodská J, Zápalka M, Smatanová D, Látalová M, Slezáková L, Radová L
Department of Pediatrics of Palacky University, Olomouc, Czech Republic.
J Asthma. 2007 May;44(4):267-71. doi: 10.1080/02770900701246915.
To explore the use of oscillometry as a measure of airway responsiveness, 69 asthmatic children underwent histamine and methacholine bronchoprovocation using dosimeter-MedicAid (Jaeger Co.; Germany) and DeVilbiss nebulizers (DeVilbiss, Bornemouth; England). The mean increase in R5 resistance in challenge testing measured after methacholine with the dosimeter-MedicAid nebulizer was 77.14% compared with 65.05% using histamine. Using the dosimeter-DeVilbiss nebulizer, the mean increases in R5 resistance following methacholine and histamine testing were 57.50% and 59.36%, respectively. The resistance R5 over R20 significantly correlated with forced expiratory volume in 1 second (FEV1). The MedicAid produced a more aggressive challenge than the DeVilbliss nebulizer. Oscillometry can be used to monitor the level of airway hyperresponsiveness following bronchoprovocation tests.
为探究振荡法作为气道反应性测量方法的应用,69名哮喘儿童使用剂量计 - 美迪科(耶格公司;德国)和德维比斯雾化器(德维比斯,伯恩茅斯;英国)进行了组胺和乙酰甲胆碱支气管激发试验。使用剂量计 - 美迪科雾化器进行乙酰甲胆碱激发试验后,R5阻力的平均增加率为77.14%,而使用组胺时为65.05%。使用剂量计 - 德维比斯雾化器时,乙酰甲胆碱和组胺试验后R5阻力的平均增加率分别为57.50%和59.36%。R5与R20的阻力与一秒用力呼气容积(FEV1)显著相关。美迪科产生的激发比德维比斯雾化器更强烈。振荡法可用于监测支气管激发试验后的气道高反应性水平。